TrianglePUBLICATIONS · 3535933
Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Breast Cancer Res Treat
- Publication date
- 1986
- First author
- Fisher B
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Fisher B
- type
- Author
- name
- Fisher ER
- type
- Author
- name
- Redmond C
- type
- Author
- name
- Brown A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Fisher B
- type
- Author
- name
- Fisher ER
- type
- Author
- name
- Redmond C
- type
- Author
- name
- Brown A
- type
- Author
- bibliography ids
- nci-bib-8d3af399d17150532c6d44f1
- book metadata
- content sha256
- 5a01fce07cf9476ad0e5f6e09d8204fdac6926a34721619295f6229b5e9897a7
- document type
- citation
- dois
- 10.1007/BF01806245
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:3535933
- immutable id
- pubmed:3535933@5a01fce07cf9476ad0e5f6e09d8204fdac6926a34721619295f6229b5e9897a7
- journal
- abbreviation
- Breast Cancer Res Treat
- issn electronic
- Source null
- issn print
- 0167-6806
- issue
- 3
- name
- Breast cancer research and treatment
- nlm unique id
- 8111104
- pages
- 147-60
- volume
- 7
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 3535933
- provenance
- batch id
- a2059861e4099d0f54b4
- provider
- NCBI PubMed ESummary
- record sha256
- e753f195ae8392ae99c8fd407138e180a24c78a5ed49e21e9edf097ab93d947f
- response sha256
- d338ccf62b1e9c7837730008fcd5c2d96e2453a423d7e449285b89d28e5a3bc3
- retrieved at
- 2026-09-09T23:45:12.786635+00:00
- publication date
- display
- 1986
- precision
- year
- year
- 1986
- publication types
- Clinical Trial
- Comparative Study
- Controlled Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/3535933/
- title
- Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer.
Preserved source evidence · Not medical advice